Abstract:Objective:Although it is believed that FSGS is a disease of podocyte,tubular injury is a common phenomena in such patients,and the degree of proteinuria is insufficient to explain the reasons.It has been reported that IL-13 could lead to podocyte injury by IL-13 receptor(IL-13R) on podocyte.Since podocyte shares many common molecules with renal tubular cell,which become molecular basis mediating podocyte and renal tubular cell common injury.To answer this question,IL-13R expression in tubular cell was observed in the renal biopsy tissues from patients with FSGS.Methodology:Fourty-one patients with idiopathic FSGS diagnosed by renal biopsy was recruited in this study.The patients with IgA nephropathy(IgAN,n=11) and membranous nephropathy(MN,n=10) served as disease controls.Five donor kidneys served as normal controls.IL-13R and RANTES(regulated on activation normal T-cell expressed and secreted) expression and distribution in renal tissue were determined by immunofluorescence staining.Tubulointerstitial lesions in FSGS patients were classified into normal,acute lesion,acute/chronic lesion and chronic lesion.The distribution and intensity of IL-13R was evaluated by scoring method.Double staining of IL-13R/N-cadherin was performed to observe IL-13R distribution.Results:The trace expression of IL-13R was found in proximal tubular cells in normal controls.The distribution and intensity of IL-13R staining was higher in FSGS patients than that in normal controls,IgAN and MN.In addition,the maximum expression of IL-13R was found in FSGS patients with looks normal tubulointerstitium and those with acute tubulointerstitial lesion,the medium expression of IL-13R in those with acute /chronic tubulointerstitial lesion and minor expression of IL-13R in those with chronic tubulointerstitial lesion.The expression and distribution of RANTES was paralleled to that of IL-13R.Reduced expression of epithelial cell marker N-cadherin was observed in the tubular cells with high expression of IL-13R.Conclusion:IL-13R was expressed in normal human renal tubular cells.The patients with FSGS had wider and higher IL-13R expression than that other glomerular diseases with same degree of proteinuria.Tubular IL-13R distribution and intensity were different according to tubulointerstitial lesions in FSGS patients.Tubular IL-13R high expression may participate in tubular cell injury in FSGS patients.

Interleukin-13 indcued podocyte injury via a signal transducer and activator of transcription-6-dependent way

STIM Promotes the Epithelial-Mesenchymal Transition of Podocytes Through Regulation of FcγRII Activity in Diabetic Nephropathy.

Mesangial Cell–Derived Exosomal Mir-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2

Effect of Autophagy and Stromal Interaction Molecule 1 on Podocyte Epithelial-Mesenchymal Transition in Diabetic Nephropathy.

[New Insight in Pathogenesis of Podocyte Disfunction in Minimal Change Disease].

Triptolide Protects Podocytes from IL-13 Induced Injury in Vitro

IL-13 and IL-4 Receptors Expression Mediat the Injury of Tubular Epithelium Cells

Tubular IL-13 Receptor Expression in Patients with Focal Segmental Glomerulosclerosis

TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation.

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Down-regulation of Integrin Β1 and Focal Adhesion Kinase in Renal Glomeruli under Various Hemodynamic Conditions.

Interleukin-22 attenuates renal tubular cells inflammation and fibrosis induced by TGF-β1 through Notch1 signaling pathway

Liver X Receptor Activation Induces Podocyte Injury Via Inhibiting Autophagic Activity

C-Maf Inducing Protein Inhibits Cofilin-1 Activity and Alters Podocyte Cytoskeleton Organization

Comprehensively characterizing cellular changes and the expression of THSD7A and PLA2R1 under multiple in vitro models of podocyte injury

Circulating T cell-derived extracellular vesicles induce podocyte injury through shuttling miR-193a

Protective role of the podocyte IL-15 / STAT5 pathway in focal and segmental glomerulosclerosis

Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway

Downregulation Of Microrna-30 Facilitates Podocyte Injury And Is Prevented By Glucocorticoids

Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage